Stay updated on Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial page.

Latest updates to the Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial page
- CheckyesterdayChange DetectedA new revision entry labeled v3.6.0 was added to the record history, representing an updated version of the study record. The previous revision v3.5.5 is now superseded in the history.SummaryDifference0.3%

- Check8 days agoChange DetectedA new revision tag v3.5.5 was added to the page's history. The previous revision tag v3.5.4 was removed from the current listing.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check30 days agoChange DetectedA new revision entry v3.5.4 is added, replacing the previous v3.5.3. This indicates a small update to the page's versioning history.SummaryDifference0.1%

- Check44 days agoChange DetectedA new revision entry, v3.5.3, was added to the history, and the previous revision v3.5.2 was removed.SummaryDifference0.1%

- Check58 days agoChange DetectedThe history now shows a new revision v3.5.2 added and the previous v3.5.0 revision removed.SummaryDifference0.1%

- Check87 days agoChange DetectedAdded revision v3.5.0 to the record history. Removed revision v3.4.3 from the record history.SummaryDifference0.1%

Stay in the know with updates to Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial page.